Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Objection Handling for Field Medical Professionals
Summary
In this episode, Linda Traylor joins Tom Caravela to delve into the art of objection handling for MSLs. They explore the nuances between MSLs and sales teams, introducing a structured approach known as the 5 e's framework. Emphasizing the significance of pre-call planning, the discussion highlights common pitfalls and strategies to prepare for frequent objections. The conversation underscores the value of team practice and the influence of MSL opinions, while stressing mentorship and collaboration. The episode wraps up with a teaser for an upcoming book review on negotiation tactics, inviting listeners to engage and apply these insights.
My guest today is Linda Traylor, Sr Principal Medical Affairs at IQVIA and we discuss objection handling for MSLs and field medical professionals.
Linda shares…
👉 How objection handling for MSLs is different than objection handling for sales reps
👉 The framework MSLs should use for objection handling
👉 What mistakes MSLs make in handling objections
👉 If MSLs should address and handle every objection
👉 The importance of preparation and pre-call planning
👉 Typical examples of objections from KOLs
MSL objection handling, 5 e's framework, medical science liaisons, pre-call planning, negotiation tactics
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Article
Sarah A. Weiss, MD, and Harriet Kluger, MD